A popular stomach-acid reducer used to prevent stress ulcers in critically ill patients needing breathing machine support increases the risk of those patients contracting pneumonia threefold.

ROCHESTER, Minn., July 7 /PRNewswire-USNewswire/ -- Chemical dependency and recovery in patients and physicians are closely examined in a series of articles and editorials in the July 2009 issue of Mayo Clinic Proceedings. The subject is especially timely.

Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that it has named six new members to its Scientific Advisory Board (SAB) to support continued development of Oxycyte™, the Company's proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.